This site is intended for U.S. audiences only.

IDHIFA® is a prescription medicine used to treat people with acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation whose disease has come back or has not improved after previous treatment(s). It is not known if IDHIFA is safe and effective in children.

Access downloadable PDFs and additional information and tools for your treatment and disease.

VISIT OUR RESOURCES AND TOOLS SECTION